1. Home
  2. LVS vs ALC Comparison

LVS vs ALC Comparison

Compare LVS & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Las Vegas Sands Corp.

LVS

Las Vegas Sands Corp.

N/A

Current Price

$53.55

Market Cap

36.0B

ML Signal

N/A

Logo Alcon Inc.

ALC

Alcon Inc.

N/A

Current Price

$78.55

Market Cap

39.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LVS
ALC
Founded
1988
1945
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Hotels/Resorts
Ophthalmic Goods
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.0B
39.9B
IPO Year
2004
2002

Fundamental Metrics

Financial Performance
Metric
LVS
ALC
Price
$53.55
$78.55
Analyst Decision
Buy
Buy
Analyst Count
13
12
Target Price
$69.46
$89.38
AVG Volume (30 Days)
3.8M
1.6M
Earning Date
04-29-2026
01-01-0001
Dividend Yield
2.19%
0.27%
EPS Growth
19.90
N/A
EPS
2.35
N/A
Revenue
$13,017,000,000.00
N/A
Revenue This Year
$7.08
$8.01
Revenue Next Year
$4.47
$6.43
P/E Ratio
$23.29
$38.31
Revenue Growth
15.22
N/A
52 Week Low
$30.18
$71.55
52 Week High
$70.45
$99.20

Technical Indicators

Market Signals
Indicator
LVS
ALC
Relative Strength Index (RSI) 35.85 38.34
Support Level $51.74 $77.10
Resistance Level $53.58 $81.84
Average True Range (ATR) 1.69 1.67
MACD -0.09 -0.67
Stochastic Oscillator 24.87 1.98

Price Performance

Historical Comparison
LVS
ALC

About LVS Las Vegas Sands Corp.

Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and Vici in 2022. After the sale of its Vegas assets, Sands generates all its EBITDA from Asia, with its casino operations generating the majority of sales.

About ALC Alcon Inc.

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Share on Social Networks: